UCSF
San Francisco, California, United States
I am a cardiologist and myocyte biologist. My clinical focus is cardio-oncology (the cardiovascular care of cancer patients and cancer survivors). My basic and translational NIH-funded laboratory addresses myocardial responses to various stresses including hypoxia, aging and toxins. Over the last several years, given my clinical interest in cardio-oncology, my laboratory focus has been in delineating the mechanistic underpinnings of cardiovascular toxicities from novel targeted cancer therapies. I believe because of the targeted nature of the toxicities, cardio-oncology can provide insights into novel signaling pathways that are relevant in human cardiovascular biology and pathology.
At UCSF, I am the William Grossman Distinguished Professor in Cardiology and Chief, Section of Cardio-Oncology, Immunology and Metabolism. I work closely with cardiologists and oncologists, basic, translational researchers and clinicians locally, nationally and internationally. I have also started several collaborations with industry and regulatory bodies (including the US FDA). I was recently named the first chair of the American Heart Association (AHA) cardio-oncology subcommittee. At UCSF, I have established a Graduate Medical Education (GME) approved fellowship training the next generation of physician-scientists in the field of cardio-oncology. I am an elected member of American Society of Clinical Investigation (ASCI).
Disclosure information not submitted.
Friday, October 21, 2022
8:05 AM – 9:50 AM
Friday, October 21, 2022
8:30 AM – 8:50 AM
Friday, October 21, 2022
9:30 AM – 9:50 AM